DOJ Cracks Down on Wound Care Fraud as Skin Substitute Cases Surge to $10 BILLION
- More investigations are coming: Federal officials have signaled a growing pipeline of cases involving wound care and skin substitutes.
- Billing and medical necessity are under the microscope: Improper documentation or unnecessary treatments could trigger legal risk.
- Compliance matters more than ever: Healthcare teams should prioritize accurate charting, ethical practice, and awareness of evolving regulations.
The U.S. Department of Justice (DOJ) is increasing its focus on potential fraud within the wound care sector, particularly involving the use of skin substitute products.
Skin substitutes, which are commonly used to promote wound healing, have become a focal point of the DOJ as they claim they may have been used fraudulently for profit.
The U.S. Department of Justice’s (DOJ) top civil fraud enforcement official, Deputy Assistant Attorney General Brenna Jenny, claimed that among a significant number of claims the DOJ is investigating, “a lot more skin substitute cases in the pipeline.”
Medicare Spending Surge Raises Red Flags
Federal agencies are now questioning whether some of that growth is tied to similar alleged inappropriate billing practices, lack of medical necessity, or inflated pricing.
Medicare spending on skin substitutes has skyrocketed from $256 million in 2019 to more than $10 billion in 2024.
Instead of assuming the investment increase is due to an aging population or other medical need, regulators, including the Centers for Medicare & Medicaid Services (CMS), attribute much of the large increase to potentially abusive pricing and use of products with limited clinical value.
In response, CMS has implemented significant payment reductions for skin substitutes beginning in 2026, aiming to curb unnecessary spending.
>>Listen to The Latest Nurse News Podcast
Recent Cases Highlight Scope of Concern
Some of the most recent skin product cases found to be fraudulent include:
A major wound care provider agreed to a $45 million settlement over allegations of overbilling for procedures that were either unnecessary or not performed.
The DOJ case claimed the physician running the wound care company pressured and incentivized his practice's physicians to do wound debridement procedures—even if the patients didn't need them—and then programmed his EHR and billing to always bill Medicaid for the highest-reimbursed procedures, even if they weren't done.
In a separate criminal case, company owners were sentenced to prison for orchestrating a $1.2 billion scheme involving medically unnecessary treatments and alleged kickbacks tied to skin substitute products.
Two Phonexis area wound care company owners schemed to have "sales representatives" order skin graft replacements for Medicare patients, even if they didn't need them, and even though the grafts were too large for their wounds. Just one of the business owners ended up with over $279 million in illegal kickbacks.
The Centers for Medicare and Medicaid Services (CMS) also explained in October 2025 that the scrutiny placed on the skin product business can be linked to the opportunity for fraud for such a high-profit product that can largely slip under a lot of people's radars.
"Current prices can reach more than $2,000 per square centimeter," they noted. "We estimate this action will reduce gross fee-for-service program spending for skin substitute services by $19.6 billion in 2026.”
What This Means for Nurses and Providers
Nurses may not see an immediate impact from the DOJ's efforts to crack down on alleged skin-substitute and wound-care fraud.
However, they may see provider or practice efforts to tighten up documentation about wound care processes and requirements in response.
For instance, nurses and providers could see:
- Increased oversight of treatment decisions
- Greater emphasis on medical necessity documentation
- More organizational focus on compliance training and reporting
There is also some dissent from some wound care providers who are concerned that the policies and wound care "crackdowns" may ultimately end up hurting patients who really do need the products and care.
Nurses, what do you think: is wound care ripe for fraud? Share your thoughts in the discussion forum below.
If you have a nursing news story that deserves to be heard, we want to amplify it to our massive community of millions of nurses! Get your story in front of Nurse.org Editors now - click here to fill out our quick submission form today!
